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Clinical effectiveness of the systematic use of the GRACE scoring
system for ischaemic outcomes and bleeding complications in the
management of NSTEMI
Charles Guenancia, Thibault Leclercq, Karim Stamboul, Carole Richard,
Aurélie Gudjoncik, Philippe Buffet, Yves Cottin, Luc Lorgis
CHU Dijon, Hôpital Bocage, Cardiologie, Dijon, France
Objectives: We assessed the interest of systematically using the GRACE
scoring system (in addition to clinical assessment) for in-hospital outcomes
and bleeding complications in the management of NSTEMI compared with
clinical assessments alone. 
Methods: Multicentre, randomized study that included 572 consecutive
NSTEMI patients, randomized 1:1, into group A: clinical stratification alone
and group B: clinical+ GRACE score stratification. 
Main Outcome Measures: In-hospital outcomes and bleeding complica-
tions. 
Results: There was no significant difference between the two groups for
baseline data or for in-hospital MACE. In multivariate analysis, only a
GRACE>140 (OR: 3.5, 95% CI: 1.8-6.6, p<0.001) and PCI (OR: 0.55, 95%
CI: 0.3-1.0; p=0.05) were independent predictors of in-hospital MACE. The
sub-analysis of group B showed that 56 patients (20%) were given a compli-
ance score of 0, showing that diagnostic angiography was performed later than
as recommended by the guidelines. Interestingly, 91% had a Grace score>140,
and these patients were significantly older, and were more likely to have a his-
tory of diabetes, stroke and renal failure, together with symptoms of heart
failure. After multivariate analysis, the independent predictors of a lack of
compliance with guideline delays were a GRACE score>140 (OR: 9.2; CI:
4.2-20.3, p<0.001) and secondary referral from a non-PCI cardiology depart-
ment (OR: 2.7; CI: 1.4-5.2, p=0.003). 
Conclusions: In a real-world setting of patients admitted with NSTEMI,
the systematic use of the GRACE scoring system at admission in the PCI
centre does not improve in-hospital outcomes and bleeding complications.
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Introduction: Iatrogenic complications are defined as adverse reactions
that can be induced by non pharmacological cause, including cardiac devices
or stimulation techniques. The use of cardiac devices has considerably
increased over the last decade. However, only few data are available on non
pharmacological iatrogeny (NPI) as cause of admission in coronary care unit
(CCU). In patients admitted in CCU for iatrogenic, we aimed to determine the
prevalence, characteristics and outcomes of NPI. 
Methods: From 1st April 2008 to 31st December 2013, all the consecutive
admissions at the coronary care unit caused by NPI defined as pacemaker
(PM), Implantable Cardioverter Defibrillator (ICD), radiofrequency ablation
(RFA), coronary angiography, valve surgery or transcatheter aortic valve
implantation (TAVI) and any other cardiac procedure were prospectively
included. Patients with NPI were compared with the other patients.
Results: Among the 11503 patients admitted in CCU over the inclusion
period, 225(2%) had NPI. The major cause of admission was conduction dis-
turbance, and acute coronary syndrome or dissection (figure).The most fre-
quent origin was coronary angiography (25%), valve intervention (22%), PM
(19%), ICD (18%). The number and rate of admission for NPI markedly
increased from 2008(n= 15(1,1%)) to 2013(n=52(2,6%)) .This trend was
mostly linked to the increase between 2008 and 2013 in new devices such as
ICD (n=4 vs n=10), TAVI ( n=0 vs n=4) and RFA (n=0 vs n=2). The intra-
hospital mortality was stable during this period for the overall patients and
patients with NPI (8% and 7%). 
Conclusion: Non pharmacological iatrogeny represents a non-negligible
cause of admission in CCU, characterized by a increased rate of complications
due to new techniques over the last 5 years. Multicentric studies are needed to
investigate this public health issue. 
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Evaluation of cannabis abuse and epidemiology in 61 young adults aged
less than 35 years old hospitalized for acute coronary syndrome.
Introduction: before the age of 35, acute coronary syndrome (ACS) are
rare. Their epidemiological characteristics are unique.
Methods: this is a retrospective single-center study at the University
Hospital of Brest of patients aged less than 35 years old hospitalized between
01/01/1998 and 31/12/2010 for ACS with or without ST segment elevation.
The initial clinical and angiographic data were collected frommedical records.
In a second phase, a questionnaire was sent to everypatient to determine their
cannabis use at the the time of the onset ofthe ACS.
Results: 61 patients were included (89,6% male). The mean age of the
patients was 31.04+ – 3 years old. Conventionnal cardiovascular risk factors
were active smoking in 86.9% of cases, coronary heredity in 40.9% cases and
dyslipidemia in 40.9% of patients. There was history of stressin 37% of cases
and a regular cannabis use in 22.9% of patients. The STelevation ACS
accounted for 68.8% of cases. They occurred during an effort in 14.8% of
cases and patient were often inaugural (68.8%). In most of cases, patients had
single vessel disease (61.7%), multivessel disease was found in 24.1% of
cases. The left anterior descending (LAD) was affected in 58.6% of cases, the
circumflex artery (CX) in 17% and right coronary artery (RCA) in 24.6% of
cases. The coronarography was normal in the ten patients who were signifi-
cantly more often cannabis smokers (50%, p<0.05). Angioplasty was the most
common method of revascularization (62.7%) with bare metal stents for
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34 patients (55%).no patient died during the hospitalization, complications
(mainly arrhythmias) occurred in 19.6% of cases.
Conclusion: ACS in the young have specific epidemiological characteris-
tics. Cannabis users represent 22.9% of this population.
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Aims: Gender differences in management of patients with acute coronary
syndromes (ACS) have been reported. The aim of this study was to evaluate
the impact of gender on myocardial revascularization in patients with ACS
from a French nationwide registry (ONACI). 
Methods and Results: We analysed data from a nationwide French pro-
spective multicentre registry including 64,932 ACS patients (mean age
65.7±13.3; 27% women, 31% ST-elevation myocardial infarction (STEMI))
recruited in 99 centres between 2004 and 2008. Women were older than men
and had higher rates of cardiovascular risk factors. Women were more likely
to have normal vessel/non-significant coronary artery disease (<50% stenosis
in all epicardial vessels; 8.4% vs. 3.8%, p<0.001) and less likely to have left-
main and three vessel disease. After adjustment for age, risk factor, and extent
of disease, myocardial revascularization (defined as the use of percutaneous
coronary intervention (PCI) or coronary artery bypass grafting) was less fre-
quently used in women than in men (adjusted OR=0.83; 95% CI: 0.78-0.87).
For those receiving PCI, In-hospital mortality occurring within 24 hours of
intervention was higher in women (3.6% vs. 1.2%; adjusted OR=0.51; 95%
IC: 1.22-1.87).
Conclusion: In the present study, women with ACS were likely to have
cardiovascular disease risk factors, but were more likely to have normal
vessel/non-significant angiographic coronary artery disease. In patients with
advanced disease, myocardial revascularization seems to be less used in
women compared to men whatever the type of ACS. Further study regarding
long-term clinical outcomes according to sex and myocardial revascularization
is warranted.
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Prognostic impact of tissue protrusion after stenting in patients with
acute coronary syndrome: an optical coherence tomography study
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Aim: The real clinical impact of Optical Coherence Tomography (OCT) –
defined abnormalities remains unknown. We investigated prognostic impact of
tissue protrusion between stent struts after stent implantation in patients with
non-ST elevation acute coronary syndromes (NSTEACS).
Methods: Prospective study of consecutive NSTEACS pts (≤72 h) under-
going PCI for an infarct-related artery presenting a single lesion without dif-
fuse disease on the culprit artery. Pts were treated at the operator’s discretion.
OCT was performed after initial coronary angiogram and at end of angioplasty
procedure. Prolapse was defined as projection of tissue (plaque/thrombus) into
the lumen between stent struts after implantation. Primary endpoint of proce-
dural complications associated no reflow + PCI-related myocardial infarction
(MI) (20% rise in troponin over baseline at 24h). Secondary endpoint was
functional result of angioplasty assessed by fractional flow reserve (FFR)
measured at end of procedure. 
Results: 43 pts were included, mean age 63±11 ans, 90% men. Tissue pro-
trusion was observed in 35(81%), tissue took up a median 8.85% [IQR 6.2-
14.2%] of intra-luminal area over a median length of 2.8mm [IQR 1.4-5.2].
Presence of protrusion was not associated with cardiovascular risk factors or
pre-treatment with aspirin, thienopyridines, antiGP IIb/IIIa or anticoagulants.
Tissue protrusion had no impact on procedural complications or FFR (Table). 
Conclusion: Tissue protrusion through struts after stent implantation is fre-
quent on OCT in NSTEACS pts undergoing angioplasty. It occludes on
average 10% of in-stent area but does not limit flow or impact on post-proce-
dural complications.
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Background: Silent Atrial Fibrillation (AF) has recently been shown to be
common in acute myocardial infarction (AMI) and to dramatically increase in-
hospital death. However, the long term prognosis of silent AF in AMI remains
unknown. 
Methods: From the 1st May 2011 and the 31st January 2013 all the
consecutive patients were prospectively analyzed by continuous ECG moni-
toring (CEM) during the first 48 hours after admission for an AMI. Silent AF
was defined as asymptomatic episodes lasting at least 30 sec. Patients dis-
charged alive and with a follow-up at 1 year were included in the present
study. Patients who developed silent AF were compared with symptomatic AF
and No AF group.
Results: Among the 737 patients included, 96 (13.0%) developed silent AF
and 56 (7.6%) developed symptomatic AF during their hospital stay.
Compared with the no AF group, patients with silent AF were markedly older
80 (64-84) vs. 61 (53-75) years; p<0.001), more frequently women (42% vs.
30%); p=0.069), and less frequently smoker (24% vs. 37%; p<0.001).GRACE
risk score was significantly higher in silent AF group (131(101-148)) than in
no AF group (98(75-); p<0.001). They also had a significant left atrial (LA)
enlargement with LA surface indexed at 10.1 (8.5-12.6) vs. 9.2 (7.4-10.9)cm²/
m²; p<0.001 and LA volume indexed 29.4 (21.0-43.1) vs. 24.1 (18.1-32.9)
cm3/m²; p<0.001. At one year follow-up, rehospitalizations for heart failure
were more frequent after silent AF (4.2%) or symptomatic AF (8.9%) than in
no AF group (1.4%), (p<0.001). One year mortality was dramatically higher
in silent AF group (9.4%) and in symptomatic AF group (17.9%) than in no
AF group (3.8%) (p<0.001). 
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No reflow 7.7% 22.2% 0 25% 0.33
Peri-procedural MI 6 (46%) 8 (80%) 6 (60%) 5 (50%) 0.39
FFR post-stenting 0.94±0.03 0.94±0.06 0.93±0.03 0.93±0.04 0.99
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